Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective

Clinical studies with cellular therapies using tolerance-inducing cells, such as tolerogenic antigen-presenting cells (tolAPC) and regulatory T cells (Treg) for the prevention of transplant rejection and the treatment of autoimmune diseases have been expanding the last decade. In this perspective, w...

Descripción completa

Detalles Bibliográficos
Autores principales: ten Brinke, Anja, Martinez-Llordella, Marc, Cools, Nathalie, Hilkens, Catharien M. U., van Ham, S. Marieke, Sawitzki, Birgit, Geissler, Edward K., Lombardi, Giovanna, Trzonkowski, Piotr, Martinez-Caceres, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395407/
https://www.ncbi.nlm.nih.gov/pubmed/30853957
http://dx.doi.org/10.3389/fimmu.2019.00181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395407/
https://www.ncbi.nlm.nih.gov/pubmed/30853957
http://dx.doi.org/10.3389/fimmu.2019.00181

Ejemplares similares